No abstract available
MeSH terms
-
Biomarkers, Tumor / analysis*
-
Breast Neoplasms / chemistry
-
Breast Neoplasms / mortality
-
Breast Neoplasms / pathology
-
Breast Neoplasms / radiotherapy
-
Breast Neoplasms / surgery*
-
Chemotherapy, Adjuvant
-
Disease-Free Survival
-
Female
-
Humans
-
Lymphatic Metastasis
-
Mastectomy, Modified Radical / adverse effects*
-
Mastectomy, Modified Radical / mortality
-
Mastectomy, Segmental* / adverse effects
-
Mastectomy, Segmental* / mortality
-
Neoplasm Invasiveness
-
Neoplasm Recurrence, Local*
-
Neoplasm Staging
-
Radiotherapy, Adjuvant
-
Receptor, ErbB-2 / analysis
-
Receptors, Estrogen / analysis
-
Receptors, Progesterone / analysis
-
Risk Assessment
-
Risk Factors
-
Time Factors
-
Treatment Outcome
Substances
-
Biomarkers, Tumor
-
Receptors, Estrogen
-
Receptors, Progesterone
-
ERBB2 protein, human
-
Receptor, ErbB-2